264 related articles for article (PubMed ID: 33178530)
1. Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature.
Iqbal QZ; Mishiyev D; Zia Z; Ruggiero RA; Aftab G
Cureus; 2020 Oct; 12(10):e10878. PubMed ID: 33178530
[TBL] [Abstract][Full Text] [Related]
2. SGLT-2 Inhibitors-a Culprit of Diabetic Ketoacidosis Postbariatric Surgery.
Iqbal QZ; Mishiyev D; Niazi MR; Zia Z; Sattar SBA; Jahanghir A; Quyyumi S
Case Rep Crit Care; 2020; 2020():8817829. PubMed ID: 33204542
[TBL] [Abstract][Full Text] [Related]
3. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
Patel K; Nair A
Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
[TBL] [Abstract][Full Text] [Related]
4. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
Diaz-Ramos A; Eilbert W; Marquez D
Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
[TBL] [Abstract][Full Text] [Related]
5. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report.
VonTungeln CD; Al Bataineh M
Cureus; 2024 Jan; 16(1):e52122. PubMed ID: 38344581
[TBL] [Abstract][Full Text] [Related]
6. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
[TBL] [Abstract][Full Text] [Related]
7. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
Chauhan S; Manov A; Dhillon GS; Shah P
Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
[TBL] [Abstract][Full Text] [Related]
8. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
Zughaib MT; Patel K; Leka M; Affas S
Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
[TBL] [Abstract][Full Text] [Related]
9. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
[TBL] [Abstract][Full Text] [Related]
10. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
Yii ESS; Azli AW; Sitaram PN
J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
[TBL] [Abstract][Full Text] [Related]
11. Post-Operative Euglycemic Diabetic Ketoacidosis in a Patient With SGLT-2 Inhibitor Use and Recent Sleeve Gastrectomy.
Smith A; Holtrop J; Sadoun M
Cureus; 2021 Apr; 13(4):e14297. PubMed ID: 33968511
[TBL] [Abstract][Full Text] [Related]
12. Euglycemic Diabetic Ketoacidosis: A Review.
Modi A; Agrawal A; Morgan F
Curr Diabetes Rev; 2017; 13(3):315-321. PubMed ID: 27097605
[TBL] [Abstract][Full Text] [Related]
13. Euglycemic diabetic ketoacidosis: A missed diagnosis.
Nasa P; Chaudhary S; Shrivastava PK; Singh A
World J Diabetes; 2021 May; 12(5):514-523. PubMed ID: 33995841
[TBL] [Abstract][Full Text] [Related]
14. "The Bitter Truth of Sugar"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series.
Shah M; Pathrose E; Bhagwat NM; Chandy D
Indian J Crit Care Med; 2022 Jan; 26(1):123-126. PubMed ID: 35110855
[TBL] [Abstract][Full Text] [Related]
15. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin.
Bader N; Mirza L
Pak J Med Sci; 2016; 32(3):786-8. PubMed ID: 27375734
[TBL] [Abstract][Full Text] [Related]
16. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a Type 2 Diabetic Patient.
Haddadin R; Aboujamra D; Iraninezhad H
Cureus; 2023 Dec; 15(12):e51184. PubMed ID: 38283482
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.
Kum-Nji JS; Gosmanov AR; Steinberg H; Dagogo-Jack S
J Diabetes Complications; 2017 Mar; 31(3):611-614. PubMed ID: 27913012
[TBL] [Abstract][Full Text] [Related]
18. Postoperative Euglycemic Ketoacidosis in Type 2 Diabetes Associated with Sodium-Glucose Cotransporter 2 Inhibitor: Insights Into Pathogenesis and Management Strategy.
Chandrakumar HP; Chillumuntala S; Singh G; McFarlane SI
Cureus; 2021 Jun; 13(6):e15533. PubMed ID: 34123681
[TBL] [Abstract][Full Text] [Related]
19. Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin.
Tiwari K; Sharma NR; Pokhrel M; Basnet A; Kaplan M
Cureus; 2023 Nov; 15(11):e49402. PubMed ID: 38149142
[TBL] [Abstract][Full Text] [Related]
20. Acute Pancreatitis-Induced Euglycemic Diabetic Ketoacidosis.
Chaudhry A; Biggiani C; Afzal M; Chaudhry S; Vwich Y
Cureus; 2021 Jun; 13(6):e15949. PubMed ID: 34336446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
